HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 625-636 of 1,811
Drug study icon
CompletedNCT00510276

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

What is this study about?

Researchers compared Atomoxetine hydrochloride and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Los Angeles
ADHDMedication studyAges 18–30
Countries
United States
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT00191048

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Official study title

Open-Label Treatment With Atomoxetine Hydrochloride in Child and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Dyslexia

This study has finished and is no longer accepting participants.

Multiple locations, including Rolling Hills Estate
ADHDMedication studyAges 10–16
Countries
United States
Sponsor
Eli Lilly and Company
Behavioral study icon
RecruitingNCT05935722

Home-based parenting support for parents with intellectual and developmental disabilities

About this title

Evaluation of a Home-based Parenting Support Program: Parenting Young Children

Read the official source — NCT05935722
Official study title

Evaluation of a Home-based Parenting Support Program - Parenting Young Children - for Parents With Intellectual and Developmental Disabilities When There is a Risk for Neglect

Multiple locations, including Enköping
ADHDBehavioural study
Countries
Sweden
Sponsor
Örebro University, Sweden
Drug study icon
CompletedNCT01174355

ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD)

What is this study about?

This study evaluated the safety and effectiveness of ND0801 for people with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Haifa
ADHDMedication studyAges 18–55
Countries
Israel
Sponsor
NeuroDerm Ltd.
Other study type icon
RecruitingACTRN12615000296538

Identifying Patterns of Executive Functions in children and adolescents with suspected Attention-Deficit-Hyperactive-Disorder using a novel computerized system: the EfA system

Official study title

In children and adolescents, is assessment of ADHD using the novel "EfA system" as effective and sensitive as other known methods in reaching a high quality and accurate diagnosis?

In New Zealand
ADHDInterventional studyAges 6–18
Countries
New Zealand
Sponsor
Dr. Yariv Doron

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.